Clinical Trial to Determine Effects of Exercise on Early Stage Prostate Cancer

Submitted by UCSF Urology on October 8, 2015 at 9:18 am
Share to Facebook Share to Twitter Share via E-mail

A new clinical trial at UCSF (Active Surveillance Dr Chan and teamExercise Randomized Clinical Trial) led by Dr. June Chan, ScD, aims to expand on the Urology Department’s previous observational findings that physical activity may help delay or prevent prostate cancer progression.

“Aerobic exercise after prostate cancer diagnosis may reduce risk of prostate cancer recurrence or mortality by 60%,” says Dr. June Chan. “This is the first study to ever definitively test the impact of exercise on the prognostic risk of men with low risk prostate cancer.”

Dr. Chan’s trial compares aerobic exercise versus usual care for men on active surveillance for early stage/low grade prostate cancer. 

Men randomized to the exercise intervention will participate in a home-based personalized exercise program developed by a UCSF exercise physiologist.  They will be asked to exercise three to five times a week for 16 weeks, and will be provided with a heart rate monitor to help them meet their exercise goals. Men assigned to the usual care group will be asked to follow their usual diet and exercise regimen, and will receive a heart rate monitor and personalized exercise plan after 16 weeks.

Dr. Chan’s team is happy to be partnering with Dr. Anthony Luke, Director of the UCSF Human Performance Center to implement this study.

All participants will receive an exercise workbook, consultation with an exercise specialist, a personalized lifestyle report, and up to $500 upon completion of the study.

If you or someone you know is interested in the study, please contact Imelda Tenggara at 415.353.7349 or [email protected].

Drs. June Chan (Right, Principal Investigator) and Stacey Kenfield (left, co-investigator) with exercise specialist Aaron Sparks (Human Performance Center) at Bakar Fitness Center.